Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
211.50    1.00 (0.47%)
Bid:
210.00
Ask:
213.00
Spread: 3.00 (1.429%)
Market Cap: £145.34m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

2022 Helios Retained Capacity

22 Dec 2021 07:01

RNS Number : 4178W
Helios Underwriting Plc
22 December 2021
Β 

22nd December 2021

Β 

Β 

Helios Underwriting plc

("Helios" or the "Company")

Β 

2022 Helios Retained Capacity

Β 

Helios, the unique investment vehicle that acquires and consolidates underwriting capacity at Lloyds', announces an update on the Company's capacity to be underwritten for 2022.

Β 

Β Nigel Hanbury, Chief Executive of Helios, commented:

Β 

"I am delighted that the retained capacity underwritten by Helios shareholders will have trebled to Β£171m for the 2022 underwriting year. This provides us with a strong platform from which to make further value-enhancing acquisitions."

Β 

Capacity Update

Helios announces that the retained underwriting capacity for Helios for the 2022 year of account will be Β£171m,Β a 191% increase in the capacity underwritten at the start of 2021. The overall portfolio including the capacity reinsured has increased to Β£233m, more than doubling the size of the portfolio.

Β 

Helios - 2022 Year of Account Capacity

Β£m

Retained

Reinsured

Total

Capacity expected as at 1st January 2022

171.1

61.6

232.7

Capacity as at 1st January 2021

58.7

51.5

110.2

% Increase

191%

20%

111%

Β 

Given the much-improved underwriting pricing going into 2022, the prospects for underwriting profitability have improved considerably and the Board believes this substantial increase in the retained capacity will benefit the Company's shareholders.

Β 

The analysis of this increase in the Helios portfolio is as follows:

Β 

Β 

Β 

Β 

2022 Capacity

Β 

Β 

Β 

Β 

Β£m

Capacity at 31 Dec 2020

Β 

Β 

110.3

Capacity expected to be acquired with LLVs in 2021

34.7

Pre-emption capacity

Β 

Β 

6.2

Acquisition of capacity in the capacity auction

23.7

Tenancy Capacity

Β 

Β 

57.8

Capacity expected at 31 Dec 2021

Β 

Β 

232.7

Β 

Β 

Β 

Β 

Β 

In addition to the capacity acquired at the capacity auctions this year, Helios has supported both new and well established syndicates that offer capacity for a limited period only, referred to as Tenancy Capacity, and Helios expects to support these syndicates in the longer term.

Β 

Helios has completed the acquisition of 26 LLVs so far in 2021 and expects to complete a further two prior to the year-end. In total, these 28 acquisitions will have added Β£35m of capacity to the 2021 year of account and increased the retained capacity for all three open years of account. The split of capacity between retained and that reinsured for the current open years of account is expected to be as follows:

Β 

Retained Capacity 2019 to 2021 Years of Account

Β 

2019

2020

2021

Β 

Β£m

Β£m

Β£m

Capacity - Position as at 1st Jan 2021

31.3

30.9

58.6

Β 

Β 

Β 

Β 

Capacity expected to be acquired during 2021

36.1

35.6

34.8

Β 

Β 

Β 

Β 

Capacity - Expected at 31st Dec 2021

67.4

66.5

93.4

Β 

The increased retained capacity on the 2019 to 2021 years of account, substantially "off-risk" for the underwriting years, will contribute to the recognised profits in the future.

Β 

Β 

Β 

For further information please contact:

Β 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

Β 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7601 6100

David Coaten

Β 

Buchanan (PR)

Helen Tarbet / Henry WilsonΒ / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately Β£145m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEAFAFAENFFAA
Date   Source Headline
25th Jun 20267:00 amRNSNet Asset Value Update - Q1 2026
22nd Jun 20263:59 pmRNSResults of Annual General Meeting
22nd Jun 20269:00 amRNSTransaction in Own Shares
15th Jun 20269:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSScrip Dividend Reference Price
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.